Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-methoxybenzyl 3-chloromethyl-7-(2-phenylacetamido)-3-cephem-4-carboxylate
2. Mfcd00191253
3. Schembl9097187
4. Dtxsid00869417
5. 4-methoxybenzyl 3-(chloromethyl)-7-(2-phenylacetamido)-3-cephem-4-carboxylate
6. Act03151
7. Bcp31228
8. Akos015964643
9. Ac-7598
10. Ls-15044
11. Sy059948
12. Db-040515
13. Ft-0602613
14. 7-phenglacetamido-3-chloromethyl-3-cephem-4-carboxylic Acid P-methoxybenzyl Ester
15. (4-methoxyphenyl)methyl 3-(chloromethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
16. 3-(chloromethyl)-7-(phenylacetylamino)-8-oxo-1-aza-5-thiabicyclo[4.2.0]octa-2-ene-2-carboxylic Acid 4-methoxybenzyl Ester
17. 4-methoxybenzyl 3-(chloromethyl)-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 487.0 g/mol |
|---|---|
| Molecular Formula | C24H23ClN2O5S |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 9 |
| Exact Mass | 486.1016207 g/mol |
| Monoisotopic Mass | 486.1016207 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 777 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Gcle:Intermediate For Cephalosporin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gcle:Intermediate For Cephalosporin, including repackagers and relabelers. The FDA regulates Gcle:Intermediate For Cephalosporin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gcle:Intermediate For Cephalosporin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gcle:Intermediate For Cephalosporin supplier is an individual or a company that provides Gcle:Intermediate For Cephalosporin active pharmaceutical ingredient (API) or Gcle:Intermediate For Cephalosporin finished formulations upon request. The Gcle:Intermediate For Cephalosporin suppliers may include Gcle:Intermediate For Cephalosporin API manufacturers, exporters, distributors and traders.
click here to find a list of Gcle:Intermediate For Cephalosporin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gcle:Intermediate For Cephalosporin DMF (Drug Master File) is a document detailing the whole manufacturing process of Gcle:Intermediate For Cephalosporin active pharmaceutical ingredient (API) in detail. Different forms of Gcle:Intermediate For Cephalosporin DMFs exist exist since differing nations have different regulations, such as Gcle:Intermediate For Cephalosporin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gcle:Intermediate For Cephalosporin DMF submitted to regulatory agencies in the US is known as a USDMF. Gcle:Intermediate For Cephalosporin USDMF includes data on Gcle:Intermediate For Cephalosporin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gcle:Intermediate For Cephalosporin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gcle:Intermediate For Cephalosporin suppliers with USDMF on PharmaCompass.
Gcle:Intermediate For Cephalosporin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gcle:Intermediate For Cephalosporin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gcle:Intermediate For Cephalosporin GMP manufacturer or Gcle:Intermediate For Cephalosporin GMP API supplier for your needs.
A Gcle:Intermediate For Cephalosporin CoA (Certificate of Analysis) is a formal document that attests to Gcle:Intermediate For Cephalosporin's compliance with Gcle:Intermediate For Cephalosporin specifications and serves as a tool for batch-level quality control.
Gcle:Intermediate For Cephalosporin CoA mostly includes findings from lab analyses of a specific batch. For each Gcle:Intermediate For Cephalosporin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gcle:Intermediate For Cephalosporin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gcle:Intermediate For Cephalosporin EP), Gcle:Intermediate For Cephalosporin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gcle:Intermediate For Cephalosporin USP).
LOOKING FOR A SUPPLIER?
